Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments

Background. The aims of this study were to assess patients' preferences to wait or start systemic treatment and understand how patients would make tradeoffs between certain severe adverse events (AEs) and additional months of progression-free survival (PFS). Materials and Methods. Adults in Fra...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Ateesha F., González, Juan Marcos, Fairchild, Angelyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677225/
https://www.ncbi.nlm.nih.gov/pubmed/26697261
http://dx.doi.org/10.1155/2015/438235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677225/
https://www.ncbi.nlm.nih.gov/pubmed/26697261
http://dx.doi.org/10.1155/2015/438235

Ejemplares similares